196 related articles for article (PubMed ID: 6206727)
1. Cytokeratin and neurofilament in lung carcinomas.
van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
[TBL] [Abstract][Full Text] [Related]
2. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors.
van Muijen GN; Ruiter DJ; Ponec M; Huiskens-van der ; Mey C; Warnaar SO
Am J Pathol; 1984 Jan; 114(1):9-17. PubMed ID: 6197887
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
6. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytoskeletal structures in hormone producing lung cancer cell cultures.
Broers JL; Gropp C; Bepler G; Rot MK; Beck J; Schaart G; Vooijs GP; Ramaekers FC
Acta Histochem Suppl; 1987; 34():57-75. PubMed ID: 2437618
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
10. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of neurofilament proteins in neuroendocrine neoplasms.
Shah IA; Schlageter MO; Netto D
Mod Pathol; 1991 Mar; 4(2):215-9. PubMed ID: 1646456
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies.
Debus E; Moll R; Franke WW; Weber K; Osborn M
Am J Pathol; 1984 Jan; 114(1):121-30. PubMed ID: 6197886
[TBL] [Abstract][Full Text] [Related]
13. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors.
Leoncini P; Bellizzi de Marco E; Bugnoli M; Mencarelli C; Vindigni C; Cintorino M
Pathol Res Pract; 1989 Dec; 185(6):848-55. PubMed ID: 2482482
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
15. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
16. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways.
Leers MP; Theunissen PH; Koudstaal J; Schutte B; Ramaekers FC
Cytometry; 1997 Feb; 27(2):179-88. PubMed ID: 9012385
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-filament proteins in parathyroid glands and parathyroid adenomas.
Miettinen M; Clark R; Lehto VP; Virtanen I; Damjanov I
Arch Pathol Lab Med; 1985 Nov; 109(11):986-9. PubMed ID: 2413822
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of human pulmonary carcinomas using monoclonal antibody 44-3A6.
Lee I; Radosevich JA; Ma YX; Combs SG; Rosen ST; Gould VE
Cancer Res; 1985 Nov; 45(11 Pt 2):5813-7. PubMed ID: 2414000
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
